Saturday – June 14th, 2025
Workshop D
| Unlocking the Potential of AI in Scientific Journal Writing: How to Use It Effectively Moderator: Dr. dr. Damai Santosa, SpPD-KHOM | |
| 09.00 – 09.45 |
From Brainstorm to Breakthrough: Can AI Ethically Fuel Scientific Discovery?
Speaker: Dr. dr. Andhika Rachman, SpPD-KHOM
|
| 09.45 – 10.30 |
From Draft to Perfection: Mastering AI tools to Edit, Proofread, and Finalize Literary Works
Speaker: dr. Tungki Pratama Umar, M.Sc
|
| 10.30 – 11.15 |
From Text to Image: Leveraging AI to Create Stunning Visualizations of Literary Worlds
Speaker: Taalenta
|
| 11.15 – 12.00 | Discussion |
Symposium Day 2
|
Symposium VI: The AI-Driven Evolution of Precision Medicine in Cancer
Unlocking the Future of Diagnostics and Therapy Moderator: Dr. dr. Cosphiadi Irawan, Sp.PD-KHOM |
|
| 08.00 – 08.20 |
Minimal Residual Disease in Cancer: Tumor-Informed vs. Tumor-Agnostic Approaches, Unraveling the Optimal Strategy
Speaker: Ahmad Rusjdan Handoyo Utomo, Ph.D
|
| 08.20 – 08.40 |
Personalized Medicine in the Multi-Omics Era: Overcoming Challenges and Shaping the Future
Speaker: Prof. dr. Sofia Mubarika, M.Med.Sc, Ph.D
|
| 08.40-09.00 |
Omics Meets AI: Unraveling Complex Data for Precision Medicine Breakthroughs
Speaker: Jun Hu, MD, PhD
|
| 09.00 -09.10 | Discussion |
| Symposium VII: Optimizing the Management of Urothelial Cancer and Renal Cell Cancer Moderator: Prof. Dr. dr. Ugroseno, Sp.PD-KHOM | |
| 09.20 – 09.40 |
Prolonging the Benefit: Extending Chemotherapy Response with Avelumab Maintenance in mUC
Speaker: dr. Agus Jati Sunggoro, Sp.PD, K-HOM, FINASIM
|
| 09.40 – 10.00 |
Striking the Right Balance: Optimizing Safety & Efficacy of Avelumab + Axitinib in RCC
Speaker: dr. Wulyo Rajabto, Sp.PD-KHOM
|
| 10.00 – 10.10 | Discussion |
|
Symposium VIII: Breaking New Ground in HER2-Low Breast Cancer
Cutting-Edge Therapies and Future Directions Moderator: dr. Ronald A. Hukom, Sp.PD-KHOM |
|
| 10.10 – 10.30 |
Targeting Her-2 low in metastatic breast cancer: an evolving treatment paradigm
Speaker: dr. Susanna Hutajulu, PhD, SpPD-KHOM
|
| 10.30 – 10.50 |
A patient journey of HER2-low mBC with Trastuzumab deruxtecan
Speaker: Dr. Joline Lim, MBBS, MRCP, M.Med, FAMS
|
| 10.50 – 11.00 | Discussion |
|
Symposium IX: Revolutionizing NSCLC Treatment
The Promise and Challenges of Immunotherapy Moderator: dr. Ridho M. Naibaho, Sp.PD-KHOM |
|
| 11.00 – 11.20 |
Pembrolizumab in Precision Oncology for Lung Cancer: Insights from Epidemiological Studies and Registry Data
Speaker: dr. Daniel Rizky, Sp.PD-KHOM
|
| 11.20 – 11.40 |
Is There a Future for Pembrolizumab in PD-L1 Non-Expressing Lung Cancer?
Speaker: dr. Johan Kurnianda, Sp.PD-KHOM
|
| 11.40 – 11.50 | Discussion |
|
Lunch Symposium I
Immunotherapy in TNBC: Addressing Challenges in Early and Advances Stages Moderator: dr. Dian Pratiwi, Sp.PD-KHOM |
|
| 11.50 – 12.10 |
Transforming Treatment Paradigms: The Impact of Preoperative Immuno-Chemotherapy Combinations in Early-Stage TNBC
Speaker: dr. Agus Jati Sunggoro, Sp.PD-KHOM
|
| 12.10 – 12.30 |
Enhancing Treatment Survival: Synergistic Immuno-Chemotherapy Combinations in Advanced-Stage TNBC
Speaker: Dr. dr. Damai Santosa, Sp.PD-KHOM
|
| 12.30 – 12.40 | Discussion |
|
Highlight Presidential Session
Challenges in Ensuring Cancer Care Quality and Accessibility Across Economic Divides Moderator: Dr. dr. Tubagus Djumhana Atmakusuma, SpPD-KHOM & Prof. dr. Catharina Suharti, PhD, SpPD-KHOM |
|
| 12.40 – 13.00 |
Scaling Up with Standards: Harmonizing Quantity and Quality in Oncology Services
Speaker: dr. Obrin Parulian, M.Kes
|
| 13.00 – 13.20 |
Medical Oncology care for all: Overcoming Disparities in Cancer Care Across Economic Divides
Speaker: Prof. Fabrice André, MD, PhD
|
| 13.20 – 13.40 | Discussion |
|
Symposium X: Navigating the Complexity of HER2-Positive Breast Cancer with Bone Metastasis
New Frontiers in Treatment Moderator: Dr. dr. I Wayan Losen, SpPD-KHOM |
|
| 13.40 – 14.00 |
The New Frontier in HER2-Positive Breast Cancer: An In-Depth Analysis of Trastuzumab’s Efficacy and Prognostic Implications
Speaker: Dr. Joline Lim, MBBS, MRCP, M.Med, FAMS
|
| 14.00 – 14.20 |
Denosumab and Bone Metastases: An Effective Strategy for Managing Skeletal-Related Events
Speaker: Prof. Dr. dr. Ami Ashariati, SpPD-KHOM
|
| 14.20 – 14.30 | Discussion |
|
Plennary Lecture II
Confronting the Complexities: Breast Cancer in Young Women Moderator: Prof. dr. Catharina Suharti, PhD, SpPD-KHOM |
|
| 14.30 – 14.50 |
Addressing Unique Challenges of Breast Cancer in Young Women
Speaker: Prof Matteo Lambertini, MD PhD
|
| 14.50 – 15.10 | Discussion |
|
Symposium XI: Recent Breakthroughs in Non-Small Cell Lung Cancer Care and Treatment Options
A Multidisciplinary Approach Moderator: dr. Mika L. Tobing, SpPD-KHOM & dr Thomas Handoyo, SpPD-KP |
|
| 15.10 – 15.30 |
Transforming Non-Small Cell Lung Cancer Care: Today’s Insights, Tomorrow’s Vision
Speaker: Dr. Voon Pei Jye, MD, MRCP, MMED
|
| 15.30 – 15.50 |
The Efficacy and Safety of Lorlatinib Post 5-Year Evaluation for ALK Positive NSCLC (CROWN Study)
Speaker: Dr. dr. Pandji Irani Fianza, MSc, SpPD-KHOM
|
| 15.50 – 16.00 | Discussion |
| Symposium XII: Breaking New Barriers in Hodgkin’s Lymphoma Therapy Moderator: Prof. Dr. dr. Ibnu Purwanto, SpPD-KHOM | |
| 16.00 – 16.20 |
Recent Advances in The Treatment of Hodgkin’s Lymphoma: A Focus on Brentuximab Vedotin
Speaker: Dr. dr. Damai Santosa, SpPD-KHOM
|
| 16.20 – 16.40 |
Real World Impact: Bridging Between Clinical Trial and Real-World Experience in R/R Hodgkin’s Lymphoma
Speaker: Dr. dr. Mardiah Suci, SpPD-KHOM
|
| 16.40 – 16.50 | Discussion |
